Miami Cancer Institute Continues to Grow its Urologic Oncology Team with the Addition of Jorge Caso, M.D.
MIAMI, FL – August 15, 2017 — Urologic oncologist Jorge Caso, M.D., joins the team of multidisciplinary cancer care experts at Miami Cancer Institute, a part of Baptist Health South Florida. Dr. Caso will work alongside renowned urologic oncologic surgeon Murugesan Manoharan, M.D., Miami Cancer Institute’s Chief of Urologic Oncologic Surgery, to provide innovative urologic cancer care. Dr. Caso specializes in the surgical treatment of various urologic conditions, including kidney, prostate, bladder and testicular cancers. Urological cancers are among the most common cancers in the U.S., accounting for one in three of all cancers in men, and one in five of all cancers in the general population.
Dedicated to the highest standard of patient care, Dr. Caso will provide cutting-edge treatment options such as laparoscopic robotic surgery. He also will collaborate with radiation oncologists at the Institute to determine the best multi-disciplinary care for his patients.
“Treating cancer effectively requires a team approach by the highest-qualified specialists,” said Michael J. Zinner, M.D., founding CEO and executive medical director of Miami Cancer Institute. “Dr. Caso brings talent and innovation in urologic cancer care, and his addition to our team reaffirms our commitment to providing world-class, personalized and comprehensive care under one roof.”
Dr. Caso earned a master’s degree in public health from the University of South Florida in Tampa. He earned his medical degree and completed a surgery internship and urology residency at the University of South Florida College of Medicine. His postdoctoral training also includes a fellowship in urologic oncology at Duke University Medical Center in Durham.
Dr. Caso is board certified by the American Board of Urology. He has authored more than 25 articles published in prestigious scientific journals. He serves as a voluntary urology faculty member at Florida International University’s Herbert Wertheim College of Medicine. Prior to joining Miami Cancer Institute at the Baptist Hospital campus, Dr. Caso was an attending urologist and assistant professor of urology at the Columbia University Division of Urology at Mount Sinai Medical Center in Miami Beach.
About Miami Cancer Institute
Baptist Health South Florida is developing Miami Cancer Institute into a destination cancer center known for its leading clinical care, compassionate patient experience, advanced clinical research and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean. To accelerate its mission of hope, caring and innovation, Miami Cancer Institute has joined the Memorial Sloan Kettering Cancer Alliance, a meaningful partnership that affords patients with cancer access to potential breakthrough therapies in South Florida. For more information, visit MiamiCancerInstitute.com.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with eight hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Fishermen’s Community Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), more than 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has approximately 16,000 employees and 2,300 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/newsroom and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF.
# # #
